Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2000
05/17/2000CN1052512C Process for producing 2-keto-L-gulonate or its salt
05/17/2000CN1052509C Process for producing nitrile hydratase
05/16/2000US6063988 DNA sequences encoding stilbene synthases and their use
05/16/2000US6063986 Polypeptide compounds and nucleotide sequences promoting resistance to eutypa dieback in plants
05/16/2000US6063903 Ligands for EPH-like receptors
05/16/2000US6063902 Amino acid sequence of protein from fleas; for prevention/treatment of allergy dermatitis in animals; antiinflammatory agents; pesticides
05/16/2000US6063760 Proteins with amino acid sequences
05/16/2000US6063756 Insecticidal polypeptides
05/16/2000US6063614 Transformed fungal strains free of selection marker
05/16/2000US6063611 Alkaline cellulase and method of producing same
05/16/2000US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals
05/16/2000US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents
05/16/2000US6063607 Polypeptides having choline oxidase activity and nucleic acids encoding same
05/16/2000US6063605 Nucleotide sequences coding a protein that is and insecticide against lepidoptera, coleoptera and diptera
05/16/2000US6063602 Lipopolysaccharide biosurfactant
05/16/2000US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection
05/16/2000US6063596 G-protein coupled receptors associated with immune response
05/16/2000US6063594 DNA encoding a novel human anion channel
05/16/2000US6063409 Species cryptococcus nodaensis, a process for producing salt-resistant thermostable glutaminase by use of the same, and a process for producing glutamic acid-rich protein hydrolysates
05/16/2000US6063386 Recombinant multivalent M protein vaccine
05/16/2000US6063377 Rho protein
05/16/2000CA2131826C Mn gene and protein
05/16/2000CA2129969C Dna encoding 5-ht4 serotonin receptors and uses thereof
05/16/2000CA2028119C Process for producing nucleosides
05/16/2000CA1340992C Process for the production of recombinant porcine growth hormone polypeptides
05/11/2000WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
05/11/2000WO2000026408A2 A system for cell-based screening
05/11/2000WO2000026407A1 Method for determining cancer by determining expression of mage-10
05/11/2000WO2000026405A1 Apparatus and method for lysing bacterial spores to facilitate their identification
05/11/2000WO2000026401A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA)
05/11/2000WO2000026396A1 A method of recombination and agents useful for same
05/11/2000WO2000026387A1 Vector for the transformation of phaffia rhodozyma and process of transformation thereby
05/11/2000WO2000026383A1 Alpha 1,2-fucosyltransferase from helicobacter pylori
05/11/2000WO2000026382A1 Thioredoxin reductase ii
05/11/2000WO2000026381A2 High fidelity thermostable ligase and uses thereof
05/11/2000WO2000026380A1 Rotavirus subunit vaccine
05/11/2000WO2000026379A2 Polypeptide mediating cell permeability
05/11/2000WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000WO2000026375A2 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
05/11/2000WO2000026372A1 Myosin heavy chain homolog
05/11/2000WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
05/11/2000WO2000026369A1 Isolated vshk-1 receptor polypeptides and methods of use thereof
05/11/2000WO2000026368A2 Therapeutic antiangiogenic endostatin compositions
05/11/2000WO2000026360A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000WO2000026355A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism
05/11/2000WO2000026354A1 Glycosylated proteins having reduced allergenicity
05/11/2000WO2000026349A2 Recombinant oleandolide polyketide synthase
05/11/2000WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/11/2000WO2000026341A1 A mixed microbial population designated as jsb 98.0 capable of degrading fecal material of animals
05/11/2000WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/11/2000WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators
05/11/2000WO2000026240A2 Streptococcal alpha2m-binding protein
05/11/2000WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
05/11/2000WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
05/11/2000WO2000026230A1 Low allergenic protein variants
05/11/2000WO2000026227A1 Ldl related protein and uses thereof
05/11/2000WO2000025908A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating
05/11/2000WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
05/11/2000WO2000025725A2 Functional antagonists of hedgehog activity
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
05/11/2000WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
05/11/2000WO2000008164A3 Thermostable in vitro complex with polymerase activity
05/11/2000WO2000008159A3 Production and use of modified cystatins
05/11/2000WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
05/11/2000WO2000007571A3 Formulations having probiotically active microorganisms
05/11/2000WO1999054460A3 Human nucleic acid sequences of normal bladder tissue
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000WO1999027100A9 Fibroblast growth factor-19
05/11/2000DE19942048A1 Hygienic, virulent beer yeast culturing plant responsive to brewing demands, comprises heated and cooled tank with sterile basal aeration
05/11/2000DE19935156A1 Bio decomposition of polyesters containing aromatic groups e.g. for denier reduction of polyester fibres and fabrics, is accomplished by contact with selected microorganisms possessing the necessary activity
05/11/2000DE19850822A1 Restraining foam formation during handling and fermentation of organic materials to produce biogas by addition of silicon-containing antifoams
05/11/2000CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/11/2000CA2350085A1 Methylated cpg island amplification (mca)
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349759A1 Isolated vshk-1 receptor polypeptides and methods of use thereof
05/11/2000CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2349495A1 Nucleic acids and polypeptides specific for pathogenic strains of the neisseria genus
05/11/2000CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
05/11/2000CA2349428A1 Alpha 1,2-fucosyltransferase from helicobacter pylori
05/11/2000CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
05/11/2000CA2349212A1 Myosin heavy chain homolog
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348962A1 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism
05/11/2000CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2348938A1 Low allergenic protein variants
05/11/2000CA2348822A1 Glycosylated proteins having reduced allergenicity
05/11/2000CA2348777A1 Rotavirus subunit vaccine
05/11/2000CA2348774A1 Therapeutic antiangiogenic endostatin compositions
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators
05/11/2000CA2348481A1 Vector for the transformation of phaffia rhodozyma and process of transformation thereby
05/11/2000CA2348421A1 Protein
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347412A1 Recombinant oleandolide polyketide synthase
05/11/2000CA2317808A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 1489